|
RNF19A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.916200E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.120700E-03 |
| Normal-vs-Stage2 |
9.964800E-01 |
| Normal-vs-Stage3 |
1.955280E-03 |
| Normal-vs-Stage4 |
7.392800E-01 |
| Stage1-vs-Stage2 |
7.782400E-02 |
| Stage1-vs-Stage3 |
4.842800E-01 |
| Stage1-vs-Stage4 |
3.508200E-01 |
| Stage2-vs-Stage3 |
1.003590E-01 |
| Stage2-vs-Stage4 |
7.568600E-01 |
| Stage3-vs-Stage4 |
2.861800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.560500E-02 |
| Normal-vs-AfricanAmerican |
3.999500E-03 |
| Normal-vs-Asian |
9.218800E-03 |
| Caucasian-vs-AfricanAmerican |
2.618800E-01 |
| Caucasian-vs-Asian |
9.518500E-02 |
| AfricanAmerican-vs-Asian |
4.953200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.079600E-03 |
| Normal-vs-Female |
1.529180E-01 |
| Male-vs-Female |
2.465000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.441000E-01 |
| Normal-vs-Extreme_Weight |
2.39759999999256E-05 |
| Normal-vs-Obese |
2.507000E-01 |
| Normal-vs-Extreme_Obese |
5.175700E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.207840E-01 |
| Normal_Weight-vs-Obese |
8.892600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.186400E-01 |
| Extreme_Weight-vs-Obese |
1.013980E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.661400E-01 |
| Obese-vs-Extreme_Obese |
4.345200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.819600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.647770E-01 |
| Normal-vs-Age(61-80Yrs) |
1.044830E-03 |
| Normal-vs-Age(81-100Yrs) |
3.831100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.381400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.845360E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.707590E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.822200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.501800E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.490840E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.786370E-02 |
| Normal-VS-Type2 PRCC |
2.264500E-03 |
| Normal-VS-KIRP CIMP |
4.027800E-01 |
| Normal-VS-Unclassified PRCC |
1.155600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.172210E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.950300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.938400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.170000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.120600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.284300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.119730E-02 |
| Normal-vs-N1 |
9.681600E-01 |
| Normal-vs-N2 |
7.557200E-01 |
| N0-vs-N1 |
9.702300E-02 |
| N0-vs-N2 |
5.102200E-01 |
| N1-vs-N2 |
6.298200E-01 |
|
|
